Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN)

Running, not enrolling · Phase 3

Conditions studied: Diabetic Peripheral Neuropathic Pain

In brief

The purpose of this study is to evaluate the long-term safety and tolerability of SUZ and long-term effectiveness of SUZ in treating pain associated with DPN.

Key facts

Study ID
NCT06696443
Run by
Vertex Pharmaceuticals Incorporated
People needed
455
Starts
2024-12-18
Expected to finish
2027-01-25
Last updated by the study team
2026-05-18

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.